Cited by 810T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and Interactions

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells

Open access
Rincón, Mercedes, Anguita, Juan, Nakamura, Tetsuo, Fikrig, Erol, Flavell, Richard A.·1997·The Journal of Experimental Medicine

Abstract

Interleukin (IL)-4 is the most potent factor that causes naive CD4+ T cells to differentiate to the T helper cell (Th) 2 phenotype, while IL-12 and interferon γ trigger the differentiation of Th1 cells. However, the source of the initial polarizing IL-4 remains unclear. Here, we show that IL-6, probably secreted by antigen-presenting cells, is able to polarize naive CD4+ T cells to effector Th2 cells by inducing the initial production of IL-4 in CD4+ T cells. These results show that the nature of the cytokine (IL-12 or IL-6), which is produced by antigen-presenting cells in response to a particular pathogen, is a key factor in determining the nature of the immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.185.3.461

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-6 directs the differentiation of IL-4-producing Th2 cells, while it inhibits the differentiation of IFNγ-producing Th1 cells.

    “In addition to the aforementioned role of IL-6 on Tfh cells, IL-6 is known to direct the differentiation of IL-4-producing T helper type 2 (Th2) cells, while it inhibits the differentiation of IFNγ-producing Th1 cells (155).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [155]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 55 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [1]Paul WE Seder RA Lymphocyte response and cytokines Cell 1994 76 241 251 7904900
  2. [7]Hsieh CS Macatonia SE Tripp CS Wolf SF O'Garra A Murphy KM Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages Science (Wash DC) 1993 260 547 549 8097338
  3. [17]Chomczynski P Sacchi N Single-step method of RNA extraction by acid guanidinium thiocyanate-phenolchloroform Anal Biochem 1987 162 156 159 2440339
  4. [25]Yamasaki K Taga T Hirata Y Yawata H Kawanishi Y See B Tanaiguchi T Hirano T Kishimoto T Cloning and expression of human interleukin-6 Science (Wash DC) 1988 241 825 828 3136546

Cited by

Sorted by citations

Authors
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A.
Affiliations
  • Howard Hughes Medical Institute (US)
  • From the *Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520-8011; ‡Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-9031; and §Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520-8011
Venue
The Journal of Experimental Medicine
Published
1997-02-03
Volume
185
Issue
3
Pages
461-470
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2150763544
Cited by
810
References
55
Citations by year
2026: 3 · 2025: 11 · 2024: 14 · 2023: 18 · 2022: 20 · 2021: 23 · 2020: 23 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 18 · 2015: 16 · 2014: 30 · 2013: 9 · 2012: 25
FWCI
29.64
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p01ai030548-09)
  • National Cancer Institute (CA-65861, R01CA065861)
  • National Institute of Allergy and Infectious Diseases (1-P01-AI30548)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
interleukin-6, IL-4, CD4+ T cells, Th2 differentiation, Th1 differentiation, antigen-presenting cells, immune regulation
MeSH terms
Animals, Antigen-Presenting Cells, Cell Differentiation, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Interleukin-4, Interleukin-6, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review